← FDA Drug Approvals (Drugs@FDA)

METHOTREXATE SODIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2026-04-15

Drug application

FDA Application #

ANDA220225

Application type

Abbreviated New Drug Application (Generic)

Brand name

METHOTREXATE SODIUM

Generic name

METHOTREXATE

Active ingredients

METHOTREXATE SODIUM

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

ALEMBIC

Manufacturer

Alembic Pharmaceuticals Inc.

First approval

2026-04-15

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown